
Danny Crichton, with TechCrunch, said "Carreyrou's tenacious and intrepid reporting at The Wall Street Journal would ultimately expose one of the largest frauds ever perpetrated in Silicon Valley . Stewart’s Den of Thieves," and "highly recommended for all collections". Work can be compared to another outstanding business exposé, James B. However, he continued by saying that "these are small issues in a book that speaks volumes to tech at large", and that, " Bad Blood is a satisfying read for anyone who wants a book full of salacious startupenfreude." Ĭharles Harry with the Library Journal said "Carreyrou's clearly written and accessible exhaustive, including interviews with more than 150 people", and said "the book stumbles a bit in its third act, when Carreyrou introduces himself and how he broke the story".

He added, "The author's description of Holmes as a manic leader who turned coolly hostile when challenged is ripe material for a psychologist Carreyrou wisely lets the evidence speak for itself." Kevin Nguyen with GQ magazine likewise called "Carreyrou’s reporting . While Roger Lowenstein from The New York Times conceded that "Carreyrou's presentation has a few minor flaws"-such as an excessive number of characters and occasional reliance on stereotypes-he concluded that "such blemishes in no way detract from the power of Bad Blood", and that "the author compellingly relates how he got involved" and "is admirably frank about his craft". In 2021, Carreyrou released a podcast called "Bad Blood: The Final Chapter" covering the trial of Elizabeth Holmes. In May 2018 Bad Blood: Secrets and Lies in a Silicon Valley Startup was published by Knopf. The articles questioned the company's claim to be able to run a wide range of lab tests from a tiny sample of blood from a finger prick. In late 2015, Carreyrou began a series of investigative articles on Theranos, published in The Wall Street Journal on the blood-testing startup founded by Elizabeth Holmes. However, after seeing Amanda Seyfried's critically acclaimed performance playing Holmes in the limited series The Dropout, Lawrence exited the project. In 2016, a film adaptation was announced, to star Jennifer Lawrence, to be written by Vanessa Taylor and to be directed by Adam McKay. The book received critical acclaim, winning the 2018 Financial Times and McKinsey Business Book of the Year Award.

It covers the rise and fall of Theranos, the multibillion-dollar biotech startup headed by Elizabeth Holmes. Bad Blood: Secrets and Lies in a Silicon Valley Startup is a nonfiction book by journalist John Carreyrou, released May 21, 2018.
